By InvitationNot Applicable

cACLD in Patients With Alcohol Use Disorder in the Hospital Detoxification Unit

Spain150 participantsStarted 2024-03-06

Plain-language summary

The aim of this study is to conduct a quick assessment of potential liver damage caused by chronic alcohol consumption. Taking advantage of the patient's admission to a specialized detoxification unit, several tests will be performed to determine the extent of liver damage through blood tests, ultrasound, and FibroScan

Who can participate

Age range18 Years – 75 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients admitted to the detoxification unit for alcohol use disorder * Patients admitted to the psychiatry unit for dual pathology with harmful alcohol consumption (\> 30 g/day in men (3 standard drinks) and \> 20 g/day in women (2 standard drinks)) Exclusion Criteria: * Refusal to undergo additional tests (blood analysis, ultrasound, and FibroScan)

What they're measuring

Prevalence of advanced chronic liver disease in patients who are electively admitted to the hospital alcohol detoxification unit

Timeframe: 5 days

Trial details

NCT IDNCT06838468

SponsorCorporacion Parc Tauli

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2024-03-12

View on ClinicalTrials.gov More Liver Disease Chronic trials